Merck & Co. Inc. (MRK) Share Price ($):45.13 Price Change: -0.19 (-0.42%)

Expand Company Information
Volume 12,501,812 Avg Volume 16,530,787
Day's Low $44.89 Day's High $45.23
52-wk Low $37.02 52-wk High $48.00
Previous Close $45.32 Open Price $45.04
Dividend $ 0.43 Yield 3.81%
Market Cap 136,399,000,000 P/E (Forward) 12.47
Chart for MRK
Exchange: NYSE Industry: Pharmaceuticals & Biotechnology Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Find a Broker »
    Article Time Date Source
    'Guided Missiles' to Treat Cancer 10:41 AM Apr 5, 2013  WSJ.com
    Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures 8:50 AM Apr 4, 2013  PR
    Merck Unit, Sun Pharma File Patent Suit Against Glenmark 11:55 AM Apr 3, 2013 Dow Jones Global News Select
    Options Traders Position for Health-Care Pullback 4:12 PM Apr 2, 2013  WSJ.com
    Merck to Hold First-Quarter 2013 Sales and Earnings Conference Call on May 1 8:29 AM Apr 1, 2013  PR
    Merck Announces FDA Acceptance of Biologics License Application for Investigational Grass Pollen Allergy Immunotherapy Tablet 7:59 AM Mar 27, 2013  PR
    Model N Shares Rise After IPO 10:20 AM Mar 20, 2013 Dow Jones Global News Select
    Improving Lives: Breakthroughs & Collaborations - Research Report on Pfizer, Merck, Bristol-Myers Squibb, J&J and Lilly 8:01 AM Mar 18, 2013  PR
    Zoetis: Too Many Folks' Pet Stock 3:38 AM Mar 16, 2013  Barrons.com
    UPDATE: Merck: FDA Extends Review of Sugammadex by 3 Months 11:21 AM Mar 15, 2013 Dow Jones Global News Select
    Merck: FDA Extends Review of Sugammadex by 3 Months 10:01 AM Mar 15, 2013 Dow Jones Global News Select
    FDA Opens Safety Review of Diabetes Drugs 12:38 PM Mar 14, 2013  WSJ.com
    FDA Conducting Safety Review Of Certain Diabetes Drugs 12:00 PM Mar 14, 2013 Dow Jones Global News Select
    Here's What a Fidelity ETF Might Look Like 12:15 PM Mar 14, 2013  Barrons.com
    Merck Signs Deal for Luminex Device to Aid Alzheimer's Study 9:55 AM Mar 13, 2013 Dow Jones Global News Select
    Critical Alerts For Merck, America Movil, Dick's Sporting Goods, US Airways, and Royal Gold Released By InvestorsObserver 9:30 AM Mar 13, 2013  PR
    Merck Signs Deal For Luminex Device to Help Screen Patients For Alzheimer's Study 9:13 AM Mar 13, 2013 Dow Jones Global News Select
    Merck and Luminex Corporation Enter Agreement to -2- 8:29 AM Mar 13, 2013  PR
    Merck and Luminex Corporation Enter Agreement to Develop Companion Diagnostic to Support Investigational BACE inhibitor Clinical Development Program for Alzheimer's Disease 8:29 AM Mar 13, 2013  PR
    A Forward Look, The Year Ahead - Research Report on United Continental Holdings Inc., Abbott Laboratories, Merck & Co., Inc., Dell Inc. and Microsoft Corporation 8:01 AM Mar 13, 2013  PR
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools